Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 5/20 | 0.55 |
| ▸ | POLB | P06746 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13255541 | 0.82 | SMN1; SMN2 (0.71) | RAB9ASMN1; SMN2NPC1KDM4EPOLB | |
| SCHEMBL26804179 | 0.79 | GAA (0.54) | RAB9ASMN1; SMN2NPC1KDM4EGAA | |
| SCHEMBL24862889 | 0.79 | RAB9A (0.61) | RAB9ASMN1; SMN2NPC1KDM4EGAA | |
| SCHEMBL38666280 | 0.78 | RAB9A (0.63) | RAB9ASMN1; SMN2NPC1KDM4EGAA | |
| SCHEMBL15926395 | 0.76 | GAA (0.61) | RAB9ASMN1; SMN2NPC1KDM4EGAA | |
| SCHEMBL7235274 | 0.75 | KDM4E (0.54) | RAB9ASMN1; SMN2NPC1KDM4EGAA | |
| SCHEMBL1521002 | 0.74 | RAB9A (0.71) | RAB9ASMN1; SMN2NPC1KDM4EGAA | |
| SCHEMBL8440269 | 0.74 | POLB (0.80) | RAB9ASMN1; SMN2NPC1KDM4EGAA | |
| SCHEMBL10497116 | 0.74 | HCAR2 (0.78) | RAB9ASMN1; SMN2NPC1KDM4EHCAR2 | |
| SCHEMBL29844215 | 0.74 | POLB (0.80) | RAB9ASMN1; SMN2NPC1KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11691983-B2 | Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes | IDEMITSU KOSAN CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11691983-B2 | Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes | KCNQ2, KCNQ1, KCNQ4 | RAB9A 2910/4885SMN1; SMN2 3638/4885NPC1 2663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.